CombiMatrix Announces Commercial Launch of Microarray

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis

IRVINE, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ: CBMX ), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis and postnatal developmental disorders and pre-implantation genetic screening (PGS) services, announces the commercial launch of its SNP microarray genetic diagnostic testing for intrauterine fetal demise (IUFD), commonly known as stillbirth genetic testing. 

“Our expansion into the underserved IUFD market is a logical extension of our current microarray genetic testing for miscarriage analysis,” said Mark McDonough, President and Chief Executive Officer of CombiMatrix.  “We estimate the annual U.S. market for IUFD is $40 million and growing as more women choose to have children later in life.  Our consistent volume and revenue growth in our miscarriage product line since its introduction in the first quarter of 2013 gives us confidence in our commercial team’s ability to capitalize on this expanded market opportunity.  We will continue to leverage our established relationships with hospital systems, OB/GYNs, maternal fetal medicine specialists and pathology laboratories to support this market expansion.  We also have the benefit of marketing tailwinds that include a growing portfolio of payer contracts and attractive reimbursement rates as well as the American College of Obstetrician and Gynecologists’ (ACOG) recommendation that microarray testing be used for IUFD. 

“We are committed to providing women and their families with important information regarding the cause of fetal loss as well as the recurrence risk for further pregnancies,” added Mr. McDonough.  “Data show that approximately half of all first trimester miscarriages are due to a fetal chromosomal abnormality; however, conventional cytogenetic analysis, such as karyotyping and fluorescence in situ hybridization (FISH), often proves to be very disappointing to patients due to high failure rates, long turnaround times and limited detection capabilities from these traditional testing modalities.  With microarray analysis, we have a greater likelihood of providing results to women who have suffered a stillbirth in 10 to 12 days as opposed to the approximately three weeks required by karyotyping, which may not yield results.  Microarray testing is clearly the best cytogenetic approach to IUFD analysis and CombiMatrix has built a reputation as one of the most experienced chromosomal microarray laboratories in the U.S., having performed more than 40,000 microarrays.”

ACOG, in a Committee Opinion No. 581, December 2013, stated that when further cytogenetic analysis is desired in IUFD, microarray analysis on fetal tissue is recommended over karyotyping as it provides superior diagnostic power with results in more than 90% cases versus 60-80% with karyotyping.  The Committee Opinion also noted the ability of microarray analysis to detect a broader range of abnormalities with the added benefit of not requiring cell culture. 

The use of microarray analysis over karyotyping is also supported by results from a clinical study conducted by the Stillbirth Collaborative Research Network.  Following the analysis of samples from 532 stillbirths, the study authors concluded that microarray is more likely than karyotyping to provide a genetic diagnosis, primarily due to its success in detecting abnormalities without the need for live cells and in cases in which karyotyping results cannot be obtained.  The study, “Karyotype Versus Microarray Testing for Genetic Anomalies after Stillbirth” Reddy, et al, was published in the New England Journal of Medicine (December 6, 2012).

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations, speak only as of the date hereof and are subject to change. All statements, other than statements of historical fact included in this press release, are forward-looking statements. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "goal," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement. The risks and uncertainties referred to above include, but are not limited to: adoption and market acceptance of our IUFD microarray test offering, our ability to add to the menu of our diagnostic tests, develop and introduce new tests and related reports, expand and improve our current suite of services, optimize the reimbursements received for our microarray testing services, and increase operating margins by improving overall productivity and expanding sales volumes; our ability to successfully accelerate sales, steadily increase the size of our customer rosters in both prenatal and developmental genetic testing markets;   our ability to attract and retain a qualified sales force in wider geographies; our ability to ramp production from our sales force and our strategic partners; rapid technological change in our markets; changes in demand for our future services; legislative, regulatory and competitive developments; the outcome of pending litigation; general economic conditions; and various other factors. Further information on potential factors that could affect our financial results is included in our Annual Report on Form 10-K, Quarterly Reports of Form 10-Q, and in other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update publicly any forward-looking statements for any reason, except as required by law.

Company Contact: Mark McDonough President & CEO, CombiMatrix Corporation (949) 753-0624 Investor Relations Contact: LHA Jody Cain (310) 691-7100 jcain@lhai.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Blueprint Strengthens Team with New Capital Markets Director

Updated Category News Views 75

Blueprint Bolsters Its Ranks Hiring Caitlin Novak as Managing Director marks a pivotal step for Blueprint Healthcare Real Estate Advisors. They aren't just swapping pawns; they're making a statement, beefing up their capital markets strategy with a heavy hitter seasoned in steering around fiscal pitfalls. Novak isn’t some rookie wet behind the ears—she's clocked more...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 133

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
SahajMobile's $25M Boost: Impact on Bangladesh Market

Updated Category News Views 128

Untapped Digital Frontier in Bangladesh There's an undeniable buzz around SahajMobile's recent $25 million credit facility, and it's one worth dissecting. This shot of capital, lined up with ALMA as part of SahajMobile’s Series A gamble, is setting the stage for a real shuffle in Bangladesh's digital landscape. Plugging into a Market Gap Ever since it hit the ground...

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 152

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
SANY's Bold AI Showdown at bauma CHINA 2026

Updated Category News Views 60

SANY's Future Vision: AI Agents and Robotic Machinery The construction machinery game is about to get a whole lot smarter, if SANY has anything to say about it. They're rolling out their biggest show ever at bauma CHINA 2026, and the headline act? A fresh breed of AI agents and robotic machinery that promises to revolutionize the industry. Marking its 40-year legacy, SANY...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
First Time Homebuyer Tips for Southern Maryland Success

Updated Category News Views 94

Shaking Up First-Time Homebuyer Assumptions Ever hear that age-old nonsense about needing a fat stack of cash as a down payment before you can snag your first home? Yeah, turns out that's about as outdated as a rotary phone. Robin Cavallaro from RE/MAX Realty Group in Annapolis is setting the record straight for first-time buyers in Southern Maryland. Down Payment Myths...

Continue Reading

Top 5 Most Recently Viewed Articles

Aardvark Therapeutics Advances Obesity Treatment Research

Updated Category News Views 140

Aardvark Therapeutics Unveils New Data on Obesity Treatments Aardvark Therapeutics, Inc. (AARD) recently showcased significant insights from its metabolic obesity pipeline at the latest conference dedicated to obesity, titled ObesityWeek 2025. This presentation highlighted the promising preclinical results of their innovative drug, ARD-201, which aims to enhance glucose...

Continue Reading
ITC Holdings Corp. Welcomes Carlo Capra as New VP of Engineering

Updated Category News Views 189

ITC Holdings Corp. Names Carlo Capra as Vice President of Engineering ITC Holdings Corp. has recently announced an important leadership change with the appointment of Carlo Capra as the company's new Vice President of Engineering, effective February 26, 2026. This move follows the retirement of Joe Bennett, who has played a vital role in ITC's development during his...

Continue Reading
Safeguarding Your Rights as a WEBTOON Entertainment Shareholder

Updated Category News Views 246

Understanding Your Rights as a WEBTOON Entertainment Shareholder Shareholders are urged to take action promptly, as the time to enforce your rights may be limited. Halper Sadeh LLC, an advocacy law firm focused on shareholder rights, is exploring claims regarding potential breaches of fiduciary duties by some officers and directors of WEBTOON Entertainment Inc. (NASDAQ:...

Continue Reading
TransDigm Group Delivers Strong First Quarter Performance

Updated Category News Views 124

TransDigm Group Reports First Quarter Results for Fiscal 2025 TransDigm Group Incorporated (NYSE: TDG), recognized as a leading designer, producer, and supplier of highly engineered aircraft components, recently announced their financial outcomes for the first quarter of fiscal 2025. First Quarter Financial Highlights In this first quarter, TransDigm Group achieved...

Continue Reading
Understanding Market Movements and TEM Stock Trends

Updated Category News Views 153

Market Activity Around Tempus AI In recent trading sessions, significant bearish sentiment has emerged around Tempus AI (TEM). This shift appears to be fueled by large investors taking notable positions that raise eyebrows among retail traders seeking insights on potential market movements. The Current Trading Landscape Today, we observed unusual activity in the options...

Continue Reading